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Background/aim: This study was conducted to determine the critical partial oxygen pressure (pO2) value that would impair hearing
function by evaluating the effects of hypoxia on hearing function in subjects diagnosed with chronic obstructive pulmonary disease
(CPOD).
Materials and methods: The study included 25 male and 5 female patients referred to our clinic who were diagnosed with COPD,
according to spirometry and PaO2 values, and who did not show pathology upon autoscopic examination. The control group consisted
of 14 female and 16 male patients who had no lung disease and were in the same age range as the COPD group.
Results: A statistically significant difference was found between the two groups for distortion-product otoacoustic emission (DPOAE)
(P < 0.001). The COPD group was divided into two groups according to pO2 levels (pO2 ≤ 70 and pO2 > 70) in order to find a critical pO2
level which might cause significant change at a certain audiological extent.
Conclusion: Hypoxia causes long-term decline in hearing thresholds, deterioration of DPOAE results, and prolongation of I–V interpeak
latency in auditory brainstem response. However, the critical oxygen level that disrupts hearing function could not be determined.
Key words: Chronic obstructive pulmonary disease, auditory brainstem response, distortion-product otoacoustic emission, hearing loss

1. Introduction
Chronic obstructive pulmonary disease (COPD) is a
progressive and irreversible systemic lung disease that
restricts airflow [1]. Irregular ventilation due to COPD
results in hypoxemia, hypercapnia, and, ultimately,
hypoxia [2]. These functional abnormalities can be
detected by arterial blood gas and pulmonary function
tests [1,3]. A decrease in partial oxygen pressure (pO2) is
known as hypoxemia, and in practice, it can be observed
in any known pulmonary disease [1]. Hypoxia is the
consequence of an inability to provide the oxygen required
for cell function. Hypoxia in COPD occurs as a result of
hypoxemia [4].
Functioning of the inner ear depends on the cochlear
oxygen supply [3]. Therefore, any decrease in oxygen
supply to the cochlea leads to a reduction in cochlear
sensitivity [3,5]. It was believed that the reactive oxygen

products released during periods of ischaemia and
reperfusion cause cochlear damage, and the extent of this
damage is due to the length and severity of the ischaemic
period [6].
Currently, how hypoxia affects the inner ear is still
unknown [7]. Conducting human experiments in artificial
hypoxic environments is quite difficult due to both ethical
issues and potential complications induced by the systemic
effects of hypoxia. Hendricks-Munoz and Walton [8]
reported a high risk of progressive hearing loss in infants
with persistent pulmonary hypertension, and Hansen [9]
suggested that exposure to hypoxia gradually decreases
cochlear function in adults. Patients with obstructive sleep
apnea were examined, and no difference was observed
in their hearing tests. This was attributed to the fact that
hypoxia occurs only during sleep, and pO2 was within
normal limits in the daytime [7]. Therefore, the study
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group was altered, and studies have been conducted with
patients with consistently low pO2 due to chronic hypoxiainduced COPD. However, testing needs to be done in a
quiet environment, and it is extremely difficult to perform
audiological tests in patients with COPD due to noisy
breathing caused by dyspnea.
In order to predict the impact on hearing function it is
important to understand the effects of hypoxia on the inner
ear, especially in infants subject to perinatal and postnatal
asphyxia. Questions that remain unanswered include: 1)
at which level does hypoxia affect hearing pathways (outer
or inner hair cells, cochlear nerve, brain stem); 2) which
audiological test is the most sensitive test for hypoxia; and
3) is there a critical oxygen value that disrupts hearing
function in hypoxia?
This study was conducted to determine the critical pO2
value that would impair hearing function by evaluating
the effects of hypoxia on hearing function in subjects
diagnosed with COPD.
2. Materials and methods
2.1. Patients
The study included 30 patients (25 male and 5 female)
diagnosed with COPD, according to spirometry and PaO2
values, and without any abnormalities upon autoscopic
examination. The patients were referred to our clinic
from the department of chest diseases. The control group
consisted of 14 female and 16 male patients with no lung
disease and in the same age range as the COPD group.
Exclusion criteria included: 1) ear-related diseases such
as acute or chronic otitis media and otosclerosis; 2) history
of noise exposure or ototoxic drug use which might affect
hearing; 3) a systematic disease other than COPD, such as
obstructive sleep apnea, that might cause hypoxia; and 4)
a difference of more than 10 dB between two ear hearing
thresholds.
Local ethics committee approval was obtained from
S.B. Dışkapı Yıldırım Beyazıt Training and Research
Hospital for this study (04.09.2008-04).
2.2 Odyological evaluation
All audiological investigations were carried out in standard
double-walled quiet rooms produced by Industrial
Acoustics Company (IAC).
2.2.1. Pure sound audiometry and speech tests
The audiometric evaluation was performed using
Interacoustics AC-40 clinical audiometry. Airway hearing
threshold measurements and speech tests were performed
using TDH-39 standard headphones, and an Oticon-60273
vibrator was used for bone path threshold measurements.
The effect of hypoxemia on hearing function is systemic
and considered similar for both ears [3]. Therefore,
the mean threshold was calculated for each ear at the
frequencies tested (250–8000 Hz), and the averages of

both ears were taken to obtain a single hearing threshold
level (HTL) for each subject.
The speech pick-up thresholds and speech
discrimination rates (SD) of the individuals included in
the study were also determined.
2.2.2. Tympanogram and acoustic reflex
The middle ear pressure, static impedance, and acoustic
reflex thresholds were evaluated using a TDH-39 headset
with an Interacoustics AZ-26 impedance meter and a 220
Hz probe tone. The arithmetic means of both middle ear
pressures were taken and statistically evaluated.
2.3. Electrophysiological evaluation
Measurements were performed in a special, dim test room.
The room was protected from the light, and the noise level
in the room did not exceed 45 dB.
2.3.1. Distortion-product otoacoustic emission
The distortion-product otoacoustic emissions (DPOAE)
(2f1-f2 cubic distortion product components) were
measured using the GSI Audera instrument in the general
diagnostic mode. The ratio between frequencies f2 and f1
(f2/f1) was fixed at 1.22. The stimulus intensity was L1 for
frequency f1 and L2 for frequency f2, and L1-L2 was fixed
at 10 dB SPL (L1 = 65, L2 = 55). The test period was about
30 s.
The evaluation of DPOAE results was based on the
signal-to-noise ratio in the frequency bands 1, 2, 4, and
8 kHz at the geometric mean of f1 and f2. The averages
of these four frequencies were taken for the right and left
ears. Statistical analysis was performed with results from
both ears.
2.3.2. Auditory brainstem response
Auditory brainstem response (ABR) was measured using
the GSI Audera device. The TIPtrode, an extratympanic
electrode, was used as the ear canal electrode. Among
other disc type electrodes, a positive electrode was placed
at the vertex (the top of the head), negative electrodes were
placed on the right and left mastoid apex, and the ground
electrode was placed on the forehead. During the test, care
was taken to ensure that the cables were not overlapping
and as far away from the device as possible. In addition,
the electrode-skin impedances were kept below 5 kΩ
during recording.
Three records were made for each ear; 11.1 click/s at
80 dB hearing level (HL) at adult alternate positive and
negative polarity were given as stimulus, and 40 dB of
masking was applied to the opposite ear during the test. At
least three repetitions were made to reliably determine the
result. When more than three repetitions were made, the
best overlapping responses were considered for analysis.
The I–V wave latencies and amplitudes and I–V
interpeak latencies (IPL) were determined. Then, I–V IPL
was recorded separately for both ears, and the mean of
both ears were statistically recorded.
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2.4. Arterial blood gas (ABG) test
The radial artery was used in all patients for ABG. The pO2
pressure of the patients was noted.
2.5. Statistical analysis
Data analysis was performed by SPSS for Windows 11.5.
The Shapiro–Wilk test was used to determine whether
distribution of continuous variables was normal. Descriptive
statistics were expressed as mean ± standard deviation or
median (minimum–maximum) for continuous variables,
and nominal variables were expressed as number of cases
and percent (%). Significance of the difference between
groups, in terms of means, was evaluated using Student’s
t-test; significance of the difference, in terms of median
values, was
 evaluated using the Mann–Whitney U test.
Nominal variables were examined with Pearson’s chisquared test. The correlation between continuous variables
was investigated with Spearman’s correlation test, and P <
0.05 was considered statistically significant.
3. Results
A total of 20 male (66.6%) and 10 female (33.3%) patients
diagnosed with COPD and with a mean age of 59.4 ± 7.8
years (range: 46–71 years) were included in this study. The
control group consisted of 15 male (50%) and 15 female
(50%) patients with a mean age of 50.7 ± 9.2 years (range:
41–75 years). The arterial blood oxygen saturation (pO2) of
subjects in the control group was 92–100 (mean: 98). In the
COPD group, the pO2 was 47–79 (mean: 62). Ten patients
with dyspnea and pO2 <60 underwent medical treatment
(bronchodilator and nasal oxygen) through chest disease
services before starting the test. The HTL, SD, DPOAE,
and ABR results of the study groups are shown in Table 1.
3.1. Hearing threshold level, acoustic reflex, speech discrimination, and tympanogram
In the pure voice audiograms of patients in the control
group who did not have any complaints about their
hearing, the mean hearing threshold level (HTL) at 250–
8000 Hz was 8.3 (2.9–29.5). This value was 31.2 (12.4–51.6)
in the COPD group. There was a statistically significant
difference between the two groups for HTL (P < 0.001).
Bilateral reflexes were positive in both COPD and
control groups, and A type tympanograms were obtained
in both groups.
The mean score of speech discrimination (SD) of both
ears was 98 (96–100) in the control group and 92 (60–100)
in the COPD group. There was a statistically significant
difference between the two groups for SD value (P < 0.001).
3.2. DPOAE
The mean of the DPOAE signal-to-noise ratio was 17.6
(8.3–27.0) for the control group. In COPD group, this value
was 5.4 (0.2–15.0). A statistically significant difference was
found between the two groups for DPOAE (P < 0.001).
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Table 1. HTL, SD, DPOAE, and ABR results. a. Mann–Whitney
U test. B. Student’s t-test.
Control

CPOD

P-value

HTL

8.3 (2.9–29.5)

31.2 (12.4–51.6)

<0.001a

SD

98.0 (96.0–100.0)

92.0 (60.0–100.0)

<0.001a

DPOAE

17.6 (8.3–27.0)

5.4 (0.2–15.0)

<0.001a

ABR

3.8 ± 0.24

4.0 ± 0.31

0.016b

3.3. ABR
For ABR, I–V IPL was 3.8 ± 0.24 for the control group and
4.0 ± 0.31 for the COPD group. There was a statistically
significant difference between the two groups for ABR I–V
IPL (P < 0.05).
The COPD group was divided into two groups
according to pO2 levels (pO2 ≤ 70 and pO2 > 70) in order
to find a critical pO2 level which might cause a significant
change at certain audiological extent. There were no
statistically significant differences between the HTL, SD,
OAE, and ABR results of the 20 patients with pO2 ≤ 70 and
10 patients with pO2 > 70 (P > 0.05) (Table 2).
The COPD group was divided into two groups: pO2
≤ 60 and pO2 > 60. There were no statistically significant
differences between the HTL, SD, OAE, and ABR test
results of the 10 patients with pO2 ≤ 60 and 20 patients
with pO2 > 60 (P > 0.05). The 10 patients in group pO2 ≤ 60
could not tolerate the test and received medical treatment
beforehand in the chest diseases clinic (Table 3).
4. Discussion
Cochlear oxygenation is important for cochlear sensitivity.
When the pO2 pressure decreases, cells respond by reducing
their function. The primary cellular damage occurs
with reactive oxygen derivatives that are released during
reoxygenation. This damage depends on the duration of
hypoxia, its occurrence, i.e. suddenly or progressively, and,
most importantly, the sensitivity of the cells in the hypoxia
region [3,10].
In cases of average oxidative stress, the reactive oxygen
products can be compensated for by an increase in the
synthesis of the antioxidant defense system. In cases of
severe oxidative stress, direct damage to carbohydrates,
proteins, lipids, and nucleic acids results in cell death,
which renders cochlear damage inevitable. Even when
the oxidative stress improves, the cochlear damage is
irreversible. Koga et al. [11] initiated an acute severe
hypoxia attack in gerbils by obliterating the vertebral
artery for 7 days and then developed a reperfusion period
by removing the obliteration. Although the blood flow
in the vertebral artery was similar to flow during the
preischemic period, 10 days after the ischemic attack the
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Table 2. According to pO2 70 values HTL, SD, OAE, and ABR
results. a. Mann–Whitney U test b. Student’s t-test.
pO2 ≤ 70 (n = 20)

pO2 > 70 (n = 10)

P-value

HTL

29.1 (12.4–51.2)

33.9 (19.5–51.6)

0.393

SD

92.0 (60.0–100.0)

93.0 (70.0–94.0)

OAE

5.2 (0.2–15.0)

ABR

4.0 ± 0.23

Table 3. According to pO2 60 values HTL, SD, OAE, and ABR
results. a. Mann–Whitney U test b. Student’s t-test.
pO2 ≤ 60 (n = 10)

pO2 > 60 (n = 20)

P-value

HTL

29.7 (20.0–51.2)

31.2 (12.4–51.6)

0.475a

0.597a

SD

86.0 (60.0–100.0)

93.0 (70.0–100.0)

0.373a

5.9 (0.4–13.4)

a

0.872

OAE

2.75 (0.2–13.2)

5.75 (0.4–15.0)

0.055a

4.0 ± 0.49

0.913b

ABR

4.1 ± 0.23

3.9 ± 0.34

0.222b

a

loss of the inner shaky hair cells was 6.4% in the basal turn,
6.4% in the second turn, and 0.8% in the apical turn. In
addition, an 89% decrease in the spiral ganglion neuron
count was reported.
The effect of hypoxia on the cochlea has been attributed
to the metabolic alteration of various electrochemical
potentials in the ear [12]. These potentials are formed
by the metabolic activity of Na/K ions, and it is believed
that a decrease in oxygen supply diminishes this process
[10]. In chronic hypoxia, hearing loss can be prevented
by increasing the number of ion pumps in response to a
gradually decreasing oxygen supply [13,14]. Although
several studies have investigated the effect of acute hypoxia
on hearing, creating a chronic hypoxic environment
for animals is very laborious and expensive. COPD is a
perfect human model as it creates a hypoxic environment.
However, it is extremely difficult to maintain pO2 at a
constant level. Therefore, it might not be possible to
determine the critical pO2 value leading to hearing loss.
In human studies related to hypoxia, it has been
demonstrated that hypoxia decreases hearing thresholds
and further reduces SD significantly [3,8,9,15]. In our
study, we observed a statistically significant increase in
HTL in the COPD group compared to the the control
group and a significant decrease in SD compared to the
control group. Even in the patient group, there were quite
different hearing thresholds compared to the control
group. However, in our study, patients with COPD were
reluctant to enter the test room due to dyspnea. Anxiety
began to occur as test duration increased, and all patients
wanted to finish the test and receive oxygen therapy during
the test period. Therefore, patient cooperation was low
during the determination of pure voice thresholds.
Hypoxia affects otoacoustic emissions as it affects
hearing thresholds [12,14,16]. In the first 15 min following
cochlear ischemia, swelling and deterioration occurred in
the external shaky hair cells. When the external shaky hair
cells were examined more closely (ultrastructurally), it was
observed that these cells had swelling and distortion in the
mitochondria, endoplasmic reticulum, and nuclei [15,17].
Ischemic symptoms caused by acute hypoxia may not
improve during the reperfusion period. Morawski et al.
[10] found a significant decrease in the internal auditory

artery DPOAE level at each frequency, especially at high
frequencies, after 5 min of hypoxia followed by a 60-min
reperfusion period, compared to the preischemic period.
A hypoxic environment in mild hypoxia can be tolerated
by increasing the cochlear blood flow. The decrease in
DPOAE values in induced hypoxia cases where the pO2 is
between 55 and 70 is evident when the oxygen saturation
at the time of reperfusion reaches the prehypoxic value,
and the resulting free oxygen radicals are held responsible
for this [5,16]. Ischemic symptoms cause changes in the
basal region of cochlea in less time than that in the apical
region.
Sensitivity of the external shaky hair cells to hypoxia
causes deterioration in otoacoustic emissions in the early
stage of hypoxia. Some researchers have suggested that the
cochlear changes caused by hypoxia can be evaluated in
the early period by otoacoustic emission measurements
[3,10,15,17].
However, there are studies suggesting that hypoxia will
deteriorate the internal shaky hair cells earlier, and that the
first sign of hypoxia is prolongation of I–V waves in ABR
before otoacoustic emissions [16].
The most significant effect of hypoxia in ABR is I–V
prolongation in IPL [3,17]. A change in ABR waves occurs
when the pO2 value reaches the prehypoxic value after
reoxygenation, not during hypoxia. Since vasodilatation
that is developed during hypoxia increases the cochlear
blood flow, it is believed that there is no change in ABR
waves during hypoxia [15]. Prolongation of I–V IPL
after hypoxia may be due to neuronal stimulation, or it
may occur due to the destruction of free oxygen radicals
produced according to the severity of hypoxia [18].
However, it is not known whether changes in ABR waves
are caused by internal shaky hair cells, nuclei, or the brain
stem.
In our study, the ABR I–V IPL value was longer in the
COPD group than in the control group, and this difference
was statistically significant.
It is well known that hypoxia may cause alterations in
hearing thresholds and DPOAE results and prolongation
of IPL of I–V waves in IPR in the chronic period [3,4,10].
However, whether there is there a critical level of oxygen
that disrupts these values is a matter of debate. El Kady et
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al. [3] considered pO2 = 70 mmHg as a critical O2 value. In
our study, we could not determine a critical oxygen value.
We could not detect a statistically significant difference
between the hearing thresholds, DPOAE results, and ABR
I–V IPL of different patient groups with pO2 >70 and pO2
<70 or pO2 >60 and pO2 <60. However, patients with pO2
<60, in particular, did not want to enter the test room
without medical treatment. Therefore, during the test, the
pO2 was between 80 and 100. In addition, the test had to
be interrupted or the test times were kept shorter as the
indoor environment of the test room increased the anxiety
of the patients. Therefore, we were not able to determine
the critical oxygen value.

In conclusion, COPD is an excellent test environment
as it creates chronic hypoxia in humans. Hypoxia causes
a decline in hearing thresholds, deterioration of DPOAE
results, and prolongation of I–V IPL in ABR over the
long term. However, the critical oxygen level that disrupts
hearing function could not be determined. There is
significant dyspnea and related anxiety in patients with
very low pO2. Silence was not achieved in the test room
due to noisy breathing, and increased patient anxiety in
the closed test room caused the patients to terminate the
test. Therefore, it is more appropriate to conduct animal
experiments in order to determine the critical oxygen
value that will create the effect of hypoxia on cochlea.
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